Last update Dec. 19, 2020
Very Low Risk
In patients with cystic fibrosis (CF), exclusive breastfeeding should be recommended during the first 6 months; prolonged breastfeeding is beneficial for patients with CF and protects against deterioration of lung function, decreases the number of infections and improves nutritional status (Lawrence 2016 p494, Colombo 2007). Breast milk provides enzymes to facilitate digestion and absorption of nutrients (Lawrence 2016 p494).
Exclusive breastfeeding for more than 6 months is associated with less serious disease and less use of intravenous antibiotics in patients with CF (Parker 2004).
Gastroenterology and Nutrition consensus and protocols from Europe (Turck 2016, Sermet 2010, Sinaasappel 2002) and the US (Borowitz 2002) recommend breastfeeding as the main source of nutrition during the first year of life in patients with cystic fibrosis.
The specialized support of certified lactation consultants (International Board Certified Lactation Consultant - IBCLC) has shown a longer duration of breastfeeding in infants with CF (Miller 2019).
For the management of pancreatic exocrine insufficiency, doses need to be correct and modern preparations of pancreatic enzymes should be used to avoid irritation of the infant's mouth and the mother's nipples (Sinaasappel 2002). Infants require 2,000 to 4,000 IU of lipase per breast-feeding (NASPGHAN 2018, Sojo 2009).
Specific indications for supplements of Vitamin K, sodium and pancreatic enzyme replacement therapy to exclusively breastfed infants are necessary (Turck 2016, Sermet 2010).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.